IRIS

SANTORO, MASSIMO

SANTORO, MASSIMO  

DIPARTIMENTO DI MEDICINA MOLECOLARE E BIOTECNOLOGIE MEDICHE  

Mostra records
Risultati 1 - 20 di 340 (tempo di esecuzione: 0.042 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Molecular mechanisms of RET activation in human cancer 2.1 Contributo in volume (Capitolo o Saggio) 2002 Santoro, Massimo; Melillo, Rosa Marina; Carlomagno, F; Fusco, Alfredo; Vecchio, Giancarlo
Ret-mediated mitogenesis requires Src kinase activity. 1.1 Articolo in rivista 1999 Melillo, Rosa Marina; Barone, Mv; Lupoli, G; Cirafici, Am; Carlomagno, F; Visconti, R; Matoskova, B; Di Fiore, Pp; Vecchio, G; Fusco, Alfredo; Santoro, Massimo
Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27(kip1). 1.1 Articolo in rivista 2002 Baldassarre, G; Bruni, P; Boccia, A; Salvatore, G; Melillo, ROSA MARINA; Motti, Ml; Napolitano, M; Belletti, B; Fusco, Alfredo; Santoro, Massimo; Viglietto, G.
Conditional expression of RET/PTC induces a weak oncogenic drive in thyroid PCCL3 cells and inhibits thyrotropin action at multiple levels. 1.1 Articolo in rivista 2003 Wang, J; Knauf, Ja; Basu, S; Puxeddu, E; Kuroda, H; Santoro, Massimo; Fusco, Alfredo; Fagin, Ja
membro Editorial board 8.06 Partecip. Editorial Board di riviste scientifiche 2007 Santoro, Massimo
Identification of a chimeric gene frequently activated in human thyroid papillary carcinomas 2.1 Contributo in volume (Capitolo o Saggio) 1993 Vecchio, Giancarlo; Fusco, Alfredo; Grieco, M.; Santoro, Massimo; Berlingieri, M.; Pierotti, M.; Della Porta, G.
Molecular Mechanism of RET in Human Cancer 2.1 Contributo in volume (Capitolo o Saggio) 2002 Santoro, Massimo; Melillo, ROSA MARINA; Carlomagno, F.; Fusco, Alfredo; Vecchio, Giancarlo
Anticorpi monoclonali e peptidi verso specifiche proteine segnale in tumori endocrini. 8.07 Progetti di Ricerca Finanziati 2007 Santoro, Massimo
Tyrosine 1062 of RET-MEN2A mediates activation of Akt(PKB) and MAPK pathways leading to PC12 cell survival. 1.1 Articolo in rivista 2000 DE VITA, G; Melillo, ROSA MARINA; Carlomagno, C; Visconti, R; Castellone, Md; Bellacosa, A; Billaud, M; Fusco, Alfredo; Tsichlis, Pn; Santoro, Massimo
Molecular Mechianism of RET Activation In Human Neoplasia 2.1 Contributo in volume (Capitolo o Saggio) 2002 Santoro, Massimo; Carlomagno, F.; Melillo, ROSA MARINA; Vecchio, Giancarlo; Fusco, Alfredo
Editorial Board Member 8.06 Partecip. Editorial Board di riviste scientifiche 2009 Santoro, Massimo
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2). 1.1 Articolo in rivista 2003 Carlomagno, F; Vitagliano, D; Guida, T; Basolo, F; Castellone, Md; Melillo, ROSA MARINA; Fusco, Alfredo; Santoro, Massimo
Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes. 1.1 Articolo in rivista 2003 Castellone, Md; Cirafici, Am; DE VITA, G; DE FALCO, V; Malorni, L; Tallini, G; Fagin, Ja; Fusco, Alfredo; Melillo, ROSA MARINA; Santoro, Massimo
Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase 1.1 Articolo in rivista 2002 Salvatore, Giuliana; Nagata, S.; Billaud, M.; Santoro, Massimo; Vecchio, Giancarlo; Pastan, I.
The neuron-specific Rai (ShcC) adaptor protein inhibits apoptosis by coupling Ret to the phosphatidylinositol 3-kinase/Akt signaling pathway. 1.1 Articolo in rivista 2002 Pelicci, G; Troglio, F; Bodini, A; Melillo, ROSA MARINA; Pettirossi, V; Coda, L; DE GIUSEPPE, A; Santoro, Massimo; Pelicci, Pg
The RET receptor: function in development and dysfunction in congenital malformation. 1.1 Articolo in rivista 2001 Manie, S; Santoro, Massimo; Fusco, Alfredo; Billaud, M.
RET activation and clinicopathologic features in poorly differentiated thyroid tumors. 1.1 Articolo in rivista 2002 Santoro, Massimo; Papotti, M; Chiappetta, G; GARCIA ROSTAN, G; Volante, M; Johnson, C; Camp, Rl; Pentimalli, F; Monaco, C; Herrero, A; Carcangiu, Ml; Fusco, Alfredo
BRAF and MEK inhibitors in the treatment of aggressive thyroid carcinomas 8.10 Tesi di Dottorato 2008 Santoro, Massimo
Is Co-option a Prevailing Mechanism during Cancer Progression? 1.1 Articolo in rivista 2011 Billaud, M; Santoro, Massimo
Oncogenic rearrangements driving ionizing radiation-associated human cancer 1.1 Articolo in rivista 2013 Santoro, Massimo; Carlomagno, Francesca